Biocon Limited has informed the Exchange regarding a press release dated March 06, 2025, titled "Biocon Biologics and Civica, Inc. Collaborate to ExpandInsulin Aspart Access in the United States".
Biocon Limited has informed the Exchange regarding a press release dated March 06, 2025, titled "Biocon Biologics and Civica, Inc. Collaborate to ExpandInsulin Aspart Access in the United States".